Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint

NCT00903565 is registered in ClinicalTrials.gov with Agendia as lead sponsor.

NCT NCT00903565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00903565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Lead sponsor
Agendia
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2008
Completion date
December 31, 2019
Enrollment
1,200 (estimated)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer